Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Am J Cardiol. 2023 Sep 6;206:42–48. doi: 10.1016/j.amjcard.2023.08.079

Table 2.

Baseline characteristics of the patients

Study Mean age (y) Male % Baseline NYHA class HTN% DM% CAD% MI% Prior HF admission %
Noe et al. 1999 F - 75.1
T - 75.1
F - 54
T - 57.3
F- 2.36
T- 2.34
F - 59.1
T - 63.1
F - 33.6
T - 44.7
NA F - 38.0
T - 45.6
NA
Stroupe et al. 2000 F - 63
T - 63
F - 35
T - 38
NA F - 47
T - 53
F - 43
T - 40
NA F - 3
T - 7
NA
Murray et al. 2001 F - 64.1
T - 64.1
F - 46
T - 49
F - 2.6
T - 2.8
F - 58
T - 61
F - 53
T - 46
F - 41
T - 35
F - 5
T - 12
F - 11
T - 25
Muller et al. 2003 F - 73.2
T - 74.4
F - 40.9
T - 45.1
F - 2.37
T - 2.47
F - 31.3
T - 27.1
F - 78.3
T - 72.1
NA F - 51.3
T - 41.8
F - 7.8
T - 13.1
Yamato et al. 2003 F - 64.9
T - 64.7
F - 60
T - 56
F - 2.6
T - 2.7
F - 24
T - 28
NA NA F - 48
T - 52
NA
Paterna et al. 2005 F - 74.3
T- 73.5
F - 67
T - 64
NA F - 21
T - 29
NA F - 52
T - 50
NA NA
TORAFIC 2011 F - 69.3
T - 68.1
F - 62
T - 55
NYHA II F - 89.7 % T - 96.1 % F - 100
T - 100
NA NA NA NA
Trippel et al. 2018 F - 69.3
T - 68
F - 39
T - 76
NYHA II F - 33 % T - 59 % F - 94
T - 100
F - 100
T - 100
F - 39
T - 53
NA F - 28
T - 76
Balsam et al. 2019 F - 65
T - 74
F - 83.3
T - 68.8
F - 2
T - 2
F - 58.3
T - 50
F - 50
T - 37.5
F - 45.8
T - 50
NA F - 67.7
T - 56.3
Mentz et al. 2023 F - 65
T - 64
F - 61
T - 65.2
NA NA F - 47.3
T - 48.1
F - 26.7
T - 29.8
NA F - 33.7
T - 37

CAD = coronary artery disease; DM = diabetes mellitus; F = furosemide; HF = heart failure; HTN = hypertension; MI = myocardial infarction; NA = not available; NYHA = New York Heart Association; T = torsemide; TORAFIC = torasemide prolonged release versus furosemide in patients with chronic heart failure; y = years.